HK Stock Market Move | |JW THERAP-B (02126) Rebounds Over 8%; Company Clarifies Cost Dispute, Expects Unit Production Cost of Benlysta to Drop Over 65% Starting Next Year
JW THERAP-B (02126) rebounded over 8%. As of press time, it rose 8.11% to HK$2.465, with a turnover of HK$3.0189 million.
JW THERAP-B (02126) rebounded over 8%, rising 8.11% as of press time to HK$2.465, with turnover of HK$3.0189 million.
On the news front, on November 18, JW Therapeutics' official WeChat account published a clarification statement regarding recent online remarks about the production costs and profitability of Benlysta. The company stated that the medical insurance payment standard for Benlysta is RMB288,600, effective from January 1, 2027. This payment standard is the result of the company's comprehensive consideration of the product's clinical value, patient accessibility, and sustainable corporate operations, reached after full communication with the national medical insurance authorities.
With the advancement of independent supply of core raw materials such as lentiviral vectors, the localization and substitution of some raw materials and consumables, and the continuous improvement of production efficiency, the company expects that starting from 2027, the unit production cost of Benlysta will decrease by more than 65% compared with the actual level in 2025. In addition, cost reduction has always been premised on not lowering quality standards. Currently, the one-time preparation success rate of commercial production of Benlysta exceeds 99%.
Related Articles

HK Stock Market Move | CHINA RES MIXC (01209) Falls Nearly 6% Again as Same-Store Sales Growth at Mainland Malls Slows in October; Morgan Stanley Expects Sluggishness to Persist Through Q1 Next Year

BofA Securities: Maintains "Buy" Rating on BYD COMPANY (01211); Management Remains Optimistic About Domestic Market Outlook

Self-defined innovation sets a new paradigm for battery safety: Aurora Battery highlights BAIC MOTOR (01958) delivering a new "answer" for family-oriented all-terrain driving.
HK Stock Market Move | CHINA RES MIXC (01209) Falls Nearly 6% Again as Same-Store Sales Growth at Mainland Malls Slows in October; Morgan Stanley Expects Sluggishness to Persist Through Q1 Next Year

BofA Securities: Maintains "Buy" Rating on BYD COMPANY (01211); Management Remains Optimistic About Domestic Market Outlook

Self-defined innovation sets a new paradigm for battery safety: Aurora Battery highlights BAIC MOTOR (01958) delivering a new "answer" for family-oriented all-terrain driving.






